Nuestro grupo organiza más de 3000 Series de conferencias Eventos cada año en EE. UU., Europa y América. Asia con el apoyo de 1.000 sociedades científicas más y publica más de 700 Acceso abierto Revistas que contienen más de 50.000 personalidades eminentes, científicos de renombre como miembros del consejo editorial.

Revistas de acceso abierto que ganan más lectores y citas
700 revistas y 15 000 000 de lectores Cada revista obtiene más de 25 000 lectores

Abstracto

Improving Accuracy in Lung Cancer Diagnosis through Biomarker Discovery

Yehn Ching

Lung cancer is a leading cause of cancer-related deaths worldwide, necessitating the continuous development of innovative diagnostic approaches to improve early detection and patient outcomes. This comprehensive review explores the latest advancements in lung cancer diagnosis, encompassing a wide range of diagnostic modalities and techniques. We discuss the significance of early detection and its impact on prognosis, emphasizing the role of imaging modalities, biomarker discovery, and liquid biopsies. Furthermore, we delve into the emerging field of precision medicine and its implications for personalized lung cancer diagnosis and treatment. Challenges and future directions in lung cancer diagnosis are also addressed. This review aims to provide a holistic understanding of the current state of lung cancer diagnosis and guide further research efforts in this critical area of oncology.